Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Apply
CD83 CAR T Cells
Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step